ACCESSION: MSBNK-SMB_Measured-HSA031P0174001
RECORD_TITLE: Annotated; N-Acetyl-L-aspartic acid; LC-ESI-QTOF; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.24, Processed 2025.02.24, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Yu et al. Front Cell Infect Microbiol. 2022,11,763507
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS3233
COMMENT: DATASET_TITLE The gut microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis
COMMENT: DATASET_AUTHORS Die Yu, Juping Du, Xia Pu, Liyuan Zheng, Shuaishuai Chen, Na Wang, Jun Li, Shiyong Chen, Shaobiao Pan, Bo Shen
COMMENT: MS1_M/Z_AVERAGED_THRES 10.000
COMMENT: MS2_M/Z_AVERAGED_THRES 15.000
COMMENT: DATASET_FILE_NUM 59
COMMENT: NUM_AVERAGED_SPEC 37
COMMENT: RAW_SPEC {'HC9-neg_746': {'bp': 3722.0, 'sum': 6802.0}, 'HC9-neg_568': {'bp': 2403.0, 'sum': 4277.0}, 'HC17-neg_734': {'bp': 1932.0, 'sum': 5166.0}, 'HC17-neg_748': {'bp': 1493.0, 'sum': 3733.0}, 'QC3-neg_723': {'bp': 1421.0, 'sum': 3867.0}, 'HC2-neg_755': {'bp': 1414.0, 'sum': 2472.0}, 'RA2-neg_750': {'bp': 1256.0, 'sum': 2768.0}, 'RA10-neg_773': {'bp': 1229.0, 'sum': 3208.0}, 'RA13-neg_750': {'bp': 1218.0, 'sum': 2766.0}, 'HC2-neg_597': {'bp': 1207.0, 'sum': 2790.0}, 'HC10-neg_801': {'bp': 1151.0, 'sum': 2304.0}, 'RA6-neg_734': {'bp': 1044.0, 'sum': 2317.0}, 'QC2-neg_719': {'bp': 978.0, 'sum': 2891.0}, 'RA3-neg_728': {'bp': 947.0, 'sum': 2564.0}, 'HC26-neg_574': {'bp': 785.0, 'sum': 1642.0}, 'HC26-neg_789': {'bp': 782.0, 'sum': 1907.0}, 'HC18-neg_789': {'bp': 759.0, 'sum': 1674.0}, 'RA11-neg_761': {'bp': 723.0, 'sum': 1766.0}, 'HC21-neg_761': {'bp': 691.0, 'sum': 1915.0}, 'RA10-neg_601': {'bp': 682.0, 'sum': 1936.0}, 'RA15-neg_813': {'bp': 657.0, 'sum': 1115.0}, 'RA12-neg_822': {'bp': 607.0, 'sum': 1581.0}, 'RA8-neg_727': {'bp': 592.0, 'sum': 1612.0}, 'HC6-neg_741': {'bp': 549.0, 'sum': 1180.0}, 'HC3-neg_814': {'bp': 542.0, 'sum': 1216.0}, 'RA4-neg_817': {'bp': 533.0, 'sum': 1578.0}, 'RA3-neg_584': {'bp': 469.0, 'sum': 1231.0}, 'RA12-neg_595': {'bp': 448.0, 'sum': 804.0}, 'QC6-neg_761': {'bp': 445.0, 'sum': 1263.0}, 'QC8-neg_740': {'bp': 394.0, 'sum': 954.0}, 'RA16-neg_840': {'bp': 341.0, 'sum': 862.0}, 'QC5-neg_733': {'bp': 334.0, 'sum': 792.0}, 'RA15-neg_587': {'bp': 312.0, 'sum': 720.0}, 'HC12-neg_868': {'bp': 295.0, 'sum': 702.0}, 'RA9-neg_772': {'bp': 254.0, 'sum': 560.0}, 'RA17-neg_774': {'bp': 203.0, 'sum': 458.0}, 'RA22-neg_715': {'bp': 203.0, 'sum': 458.0}}
COMMENT: RETENTION_TIME_STDEV 0.136
COMMENT: PRECURSOR_M/Z_RAW 174.041639
COMMENT: PRECURSOR_M/Z_STDEV 0.000397
COMMENT: PRECURSOR_IN_MS1 mz 174.040909; int 999.000; delta(ppm) -4.583222
COMMENT: PROPOSED_CHARGE_STATE -1; mz 175.044026; int 52.701; cor 0.938
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M-H2O-H; mz 156.030002; int 26.168; cor 0.899
COMMENT: PROPOSED_ION_FORM M+Hac-H; M-H; mz 114.019630; int 26.685; cor 0.942
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 7.175; C7H5N5O; [M-H]1; delta(ppm) -7.175168
COMMENT: PROPOSED_MF SevenGoldenRules 0.468; C6H9NO5; [M-H]1; delta(ppm) 0.468443
COMMENT: PROPOSED_MF SevenGoldenRules 0.730; C4H5NO3; [M+Hac-H]1; delta(ppm) 0.730263
COMMENT: PROPOSED_MF MS-FINDER 4.601; C6H9NO5; [M-H]-; delta(ppm) 0.471311
COMMENT: PROPOSED_MF MS-FINDER 3.715; C4H5NO3; [M+Hac-H]-; delta(ppm) 540023.377936
COMMENT: PROPOSED_MF MS-FINDER 3.305; C7H5N5O; [M-H]-; delta(ppm) -7.213119
COMMENT: PROPOSED_MF MS-FINDER 2.535; C7H13NS2; [M-H]-; delta(ppm) -4.521849
COMMENT: PROPOSED_MF SIRIUS5_Sirius 25.764; C6H9NO5; [M-H]-; delta(ppm) 0.471311
COMMENT: PROPOSED_MF SIRIUS5_Sirius 17.993; C4H5NO3; [M+C2H4O2-H]-; delta(ppm) 2223066.529759
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.326; C7H5N5O; [M-H]-; delta(ppm) -7.213119
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C7H13NS2; [M-H]-; delta(ppm) -4.521849
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) 0.471311
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H5NO3; [M+C2H4O2-H]-; delta(ppm) 2223066.529759
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.543; C6H9NO5; [M-H]-; delta(ppm) 0.471311
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.543; C4H5NO3; [M+C2H4O2-H]-; delta(ppm) 2223066.529759
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.964; C5H13NO2Si2; [M-H]-; delta(ppm) -268690.791981
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.964; C3H9NSi2; [M+C2H4O2-H]-; delta(ppm) 48895.006830
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.908; C4H7N4O4; [M-H]-; delta(ppm) 8.186023
COMMENT: PROPOSED_MF SIRIUS6_Sirius 23.908; C2H3N4O2; [M+C2H4O2-H]-; delta(ppm) 2052241.915663
COMMENT: PROPOSED_MF SIRIUS6_Sirius 18.002; C7H5N5O; [M-H]-; delta(ppm) -7.213119
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.599; C3H8N6OP; [M-H]-; delta(ppm) -8.989127
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.595; C7H10FNOS; [M-H]-; delta(ppm) 8.282511
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.186; C4H7F4N2O; [M-H]-; delta(ppm) -7.443186
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.391; C7H13NS2; [M-H]-; delta(ppm) -4.521849
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.391; C12H5BO; [M-H]-; delta(ppm) 61051.711598
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.542; C2H5F4N5; [M-H]-; delta(ppm) 0.271404
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H9NO5; [M-H]-; delta(ppm) 0.471311
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H5NO3; [M+C2H4O2-H]-; delta(ppm) 2223066.529759
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 11.000; OTCCIMWXFLJLIA-BYPYZUCNSA-N; C6H9NO5; N-ACETYL-ASPARTIC ACID
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.500; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; CC(NC(=O)CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.400; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; CC(=O)N[C@@H](CC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.800; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; OCC(=N)C1OC(=O)C(O)C1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.752; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; COC(=O)CNC(=O)C(=O)OC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.750; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; OC(=O)CC(CC(O)=O)NC=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.538; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 8.112; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.854; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.694; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.510; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.380; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.349; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.269; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.191; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.038; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.274; YSPMLLKKKHCTBN-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxoazetidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.763; NQTADLQHYWFPDB-UHFFFAOYSA-N; [M+Hac-H]-; 1-hydroxypyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.589; JUBQWIQZJYAKGO-UHFFFAOYSA-N; [M+Hac-H]-; 3-cyano-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.550; FMKSMYDYKXQYRV-UHFFFAOYSA-N; [M-H]-; 7-cyano-7-deazaguanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.208; OSXKHFTZRHDUJN-UHFFFAOYSA-N; [M-H]-; N(2),3-ethenoguanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.104; JAQUADIPBIOFCE-UHFFFAOYSA-N; [M-H]-; 1,N(2)-ethenoguanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.017; HOLDJZBOPVYISO-UHFFFAOYSA-N; [M+Hac-H]-; 1-hydroxypyrrole-2,5-diol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 3.993; HBVIMVJTUQNSEP-UHFFFAOYSA-N; [M-H]-; Berteroin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FMKSMYDYKXQYRV-UHFFFAOYSA-N; [M-H]-; 7-cyano-7-deazaguanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NVEYLYRWCRKVAU-UHFFFAOYSA-N; [M-H]-; 2-oxopropanoyl 2-aminopropaneperoxoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NQTADLQHYWFPDB-UHFFFAOYSA-N; [M+Hac-H]-; 1-hydroxypyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.821; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; OSXKHFTZRHDUJN-UHFFFAOYSA-N; [M-H]-; N(2),3-ethenoguanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.661; JAQUADIPBIOFCE-UHFFFAOYSA-N; [M-H]-; 1,N(2)-ethenoguanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.643; AZKKNWAHCAZDCU-UHFFFAOYNA-N; [M-H]-; D-N-(Carboxyacetyl)alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.606; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; N-Acetyl-L-aspartic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.585; RSYBGFZORPFBEV-SEFKMRKONA-N; [M-H]-; UNPD15404
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.581; SPJCNQDVYQSGSB-UHFFFAOYNA-N; [M-H]-; 3,4-dihydroxy-5-(2-hydroxyethanimidoyl)oxolan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.573; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; N-Formyl-L-glutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.555; QXAHNKVDGAGBNU-UHFFFAOYSA-N; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.529; GIFXBNNGHVCVMF-UHFFFAOYSA-N; [M-H]-; 5-amino-2-hydroxy-2-methyl-1,3-dioxepane-4,7-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.496; HXWZRYKURKEOSO-UHFFFAOYNA-N; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.496; YSPMLLKKKHCTBN-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxoazetidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.358; HOLDJZBOPVYISO-UHFFFAOYSA-N; [M+Hac-H]-; 1-hydroxypyrrole-2,5-diol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.165; JUBQWIQZJYAKGO-UHFFFAOYSA-N; [M+Hac-H]-; 3-cyano-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; FMKSMYDYKXQYRV-UHFFFAOYSA-N; [M-H]-; 2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidine-5-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.738; OTCCIMWXFLJLIA-BYPYZUCNSA-N; [M-H]-; (2S)-2-acetamidobutanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.210; NQTADLQHYWFPDB-UHFFFAOYSA-N; [M+Hac-H]-; 1-hydroxypyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.509; FSQQTNAZHBEJLS-UPHRSURJSA-N; [M+Hac-H]-; (Z)-4-amino-4-oxobut-2-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.337; SHZGPUUYVAWLLN-UHFFFAOYSA-N; [M+Hac-H]-; 3-methyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; PMPAXURTFMSZSN-UHFFFAOYSA-N; [M+Hac-H]-; 3-methyl-1,3-oxazolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.292; BNJOZDZCRHCODO-UHFFFAOYSA-N; [M-H]-; methyl 2-[(2-methoxy-2-oxoethyl)amino]-2-oxoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.282; ZBBUWSWHUXAKGA-UHFFFAOYSA-N; [M+Hac-H]-; 5-methyl-1,3-oxazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.265; DTETYCNJKAUROO-REOHCLBHSA-N; [M+Hac-H]-; (4S)-4-methyl-1,3-oxazolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; VMVZGGPZNHFGKS-UHFFFAOYSA-N; [M+Hac-H]-; ethyl N-(oxomethylidene)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; AHTJUEXRQQZHSF-UHFFFAOYSA-N; [M+Hac-H]-; 4-imino-2-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.207; ZGONRPXUNVTWTA-UHFFFAOYSA-N; [M+Hac-H]-; methyl 2-isocyanatoacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; ADZLWSMFHHHOBV-BYPYZUCNSA-N; [M-H]-; (2S)-2-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.035; AZKKNWAHCAZDCU-UHFFFAOYSA-N; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.840; NWWNMEXBDCKKIG-JLAZNSOCSA-N; [M-H]-; (2R)-2-[(1S)-2-amino-1-hydroxyethyl]-3,4-dihydroxy-2H-furan-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.810; HQESMQVYRAJTEA-UHFFFAOYSA-N; [M-H]-; 4-(carboxymethylamino)-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.793; VZRHBEPCALFDTQ-UHFFFAOYSA-N; [M-H]-; methyl 3-(methoxycarbonylamino)-3-oxopropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; YSPMLLKKKHCTBN-UHFFFAOYSA-N; [M+Hac-H]-; 4-oxoazetidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.703; ZYDBNGULYNHMSF-UHFFFAOYSA-N; [M+Hac-H]-; 4,5-dihydro-1,2-oxazole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.685; JHLJBMKXTOOGCW-AIHAYLRMSA-N; [M-H]-; (3aS,5R,6R,6aR)-6-hydroxy-5-(hydroxymethyl)-3a,5,6,6a-tetrahydro-3H-furo[2,3-d][1,3]oxazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.399; YYPAYWPSPJDUBG-UHFFFAOYSA-N; [M+Hac-H]-; 3-(nitromethylidene)oxetane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -6.541; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -108.049; AZKKNWAHCAZDCU; [M-H]-; 3-(1-carboxyethylamino)-3-oxopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.912; YSPMLLKKKHCTBN; [M+C2H4O2-H]-; 4-oxo-2-azetidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.139; QXAHNKVDGAGBNU; [M-H]-; 3-formamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.058; FSQQTNAZHBEJLS; [M+C2H4O2-H]-; Maleamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.258; ADZLWSMFHHHOBV; [M-H]-; formylglutamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.238; WRDWXTJVALMCAN; [M-H]-; N-(Vinyloxycarbonyl)-L-serine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.331; DTETYCNJKAUROO; [M+C2H4O2-H]-; ACMC-20ahmk
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.386; VMVZGGPZNHFGKS; [M+C2H4O2-H]-; ethyl isocyanatooate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.636; SHZGPUUYVAWLLN; [M+C2H4O2-H]-; 2,4-Oxazolidinedione, 3-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.565; NQTADLQHYWFPDB; [M+C2H4O2-H]-; 2, 1-hydroxy-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.357; JMRZMIFDYMSZCB; [M+C2H4O2-H]-; 2,5-Morpholinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.637; ZBBUWSWHUXAKGA; [M+C2H4O2-H]-; 5-Methyl-2,4-oxazolidinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.354; ZGONRPXUNVTWTA; [M+C2H4O2-H]-; Methyl 2-isocyanatoacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -226.799; LQEOKGSJPWXFIT; [M+C2H4O2-H]-; triformyl(methyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.337; BNJOZDZCRHCODO; [M-H]-; dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.927; ZYDBNGULYNHMSF; [M+C2H4O2-H]-; 4,5-dihydro-1,2-oxazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.065; HXWZRYKURKEOSO; [M-H]-; 2-Amino-3-oxoadipate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -310.481; RSYBGFZORPFBEV; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.987; SPJCNQDVYQSGSB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -379.753; RTPBEMVDAXPYRC; [M-H]-; Scorbamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -384.713; NWWNMEXBDCKKIG; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.777; OTCCIMWXFLJLIA; [M-H]-; bmse000423
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.323; YSPMLLKKKHCTBN; [M+C2H4O2-H]-; 4-oxo-2-azetidinecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -28.690; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.902; YSPMLLKKKHCTBN; [M+C2H4O2-H]-; (2S)-4-oxoazetidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.400; AZKKNWAHCAZDCU; [M-H]-; 2-(2-carboxyacetamido)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.015; FSQQTNAZHBEJLS; [M+C2H4O2-H]-; Maleamic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -172.419; HOLDJZBOPVYISO; [M+C2H4O2-H]-; 1-Hydroxypyrrole-2,5-diol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.169; JUBQWIQZJYAKGO; [M+C2H4O2-H]-; 3-Cyano-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.119; LQEOKGSJPWXFIT; [M+C2H4O2-H]-; Triformyl(methyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -185.993; WRDWXTJVALMCAN; [M-H]-; 2-(Ethenoxycarbonylamino)-3-hydroxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -186.243; NQTADLQHYWFPDB; [M+C2H4O2-H]-; 1-hydroxypyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.938; JMRZMIFDYMSZCB; [M+C2H4O2-H]-; Morpholine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.231; FOCKMBBVQYRNGP; [M-H]-; Propanedioic acid, (methoxyimino)-, dimethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -202.742; ZGONRPXUNVTWTA; [M+C2H4O2-H]-; 1-hydroxy-N-(2-methoxy-2-oxoethyl)formonitrilium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -203.519; XYNXPKJAVYJHOF; [M-H]-; 3-Acetylaspartic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.424; DTETYCNJKAUROO; [M+C2H4O2-H]-; (S)-4-Methyloxazolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.481; ISTWWSBLMQHYIQ; [M-H]-; N-oxalyl-alpha-methylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -214.113; ZYDBNGULYNHMSF; [M+C2H4O2-H]-; 4,5-Dihydro-1,2-oxazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -215.587; HQESMQVYRAJTEA; [M-H]-; 4-(Carboxylatomethylamino)-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -216.987; QXAHNKVDGAGBNU; [M-H]-; N-formylisoglutamic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.117; BNJOZDZCRHCODO; [M-H]-; Dimethyloxalylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -223.949; ZQWAVKINQMTJSS; [M-H]-; 3-[(Carboxycarbonyl)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.948; OTCCIMWXFLJLIA; [M-H]-; Acetylaspartic Acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.264; YSPMLLKKKHCTBN; [M+C2H4O2-H]-; (2S)-4-oxoazetidine-2-carboxylic acid
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match N-Acetyl-L-aspartic acid, OTCCIMWXFLJLIA-BYPYZUCNSA-N; Matching to 11 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (6), MetFrag:PubchemLite (2); This structural isomer was suggested from the biological context HMDB HMDB0000812;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C6H9NO5
CH$EXACT_MASS: 175.048072
CH$SMILES: CC(=O)N[C@@H](CC(=O)O)C(=O)O
CH$IUPAC: InChI=1S/C6H9NO5/c1-3(8)7-4(6(11)12)2-5(9)10/h4H,2H2,1H3,(H,7,8)(H,9,10)(H,11,12)/t4-/m0/s1
CH$LINK: CHEBI CHEBI:16953
CH$LINK: HMDB HMDB0000812
CH$NAME: N-Acetyl-L-aspartate
CH$NAME: N-Acetyl-L-aspartic acid
CH$NAME: (2S)-2-acetamidobutanedioic acid
CH$LINK: INCHIKEY OTCCIMWXFLJLIA-BYPYZUCNSA-N
CH$LINK: PUBCHEM CID:65065
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Feces
AC$INSTRUMENT: UPLC system, AB SCIEX - TripleTOF 5600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY -30 V
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.5 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 10.00; MS2(ppm) 15.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC T3 column (1.8 µm, 100 mm x 2.1 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT 0.0-0.5 min, 5% B; 0.5-7.0 min, 100% B; 7.0-8.0 min, 100% B; 8.0-8.1 min, 5% B; 8.1-10.0 min, 5% B. 
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 1.257
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 174.040878
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-052r-9000000000-6916c98936f8ed0883f9
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  41.9986169 323.3013 41.998345 11.7623 101.71 0.8995 36 f{C1N1O1}/1.90ppm,p-C5H8O4
  58.0299052 539.2150 58.029590 9.0471 123.48 1.0000 37 f{C2H4N1O1}/1.17ppm,p-C4H4O4
  71.0135425 171.1751 71.013190 15.0675 78.54 0.7020 31 f{C3H3O2}/-4.37ppm,p-C3H5N1O3
  88.0404829 999.0000 88.040100 6.7015 0.00 0.9489 37 f{C3H6N1O2}/0.92ppm,p-C3H2O3
PK$NUM_PEAK: 4
PK$PEAK: m/z int. rel.int.
  41.998617 323.30 323
  58.029905 539.22 539
  71.013542 171.18 171
  88.040483 999.00 999
//
